Chapter 7 hiPSC-Based Tissue Organoid Regeneration

Induced pluripotent stem cells (iPSCs) are generated from terminally differentiated cells and have the potential to differentiate to any organs originated from the embryonic germ layers. Extensive effort has been made to establish protocols for direct in vitro conversion of human iPSCs (hiPSCs) to different cell types/organs. Importantly, hiPSCs can be generated from patients with known genetic mutations that predispose to high-risks of specific disease development. Thus, the hiPSCs technology provides unlimited resources for creating patient-specific disease models. hiPSC-derived three-dimensional “organoid” models have recently emerged as a powerful tool to recapitulate the physiologically-relevant process of disease progression in vitro. In this chapter, we will discuss the current advancement of organoid regeneration from hiPSCs and the applications of hiPSCs-derived organoids. The limitations and challenges of this approach will also be discussed here.

[1]  Hideyuki Okano,et al.  iPS cell technologies: significance and applications to CNS regeneration and disease , 2014, Molecular Brain.

[2]  T. Karlsen,et al.  Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation , 2015, Nature Biotechnology.

[3]  H. Niemann,et al.  The small molecule inhibitors PD0325091 and CHIR99021 reduce expression of pluripotency-related genes in putative porcine induced pluripotent stem cells. , 2014, Cellular reprogramming.

[4]  Kumaraswamy Nanthakumar,et al.  Biowire: a New Platform for Maturation of Human Pluripotent Stem Cell Derived Cardiomyocytes Pubmed Central Canada , 2022 .

[5]  Gail H Deutsch,et al.  In vitro generation of human pluripotent stem cell derived lung organoids , 2015, eLife.

[6]  J. Cashman,et al.  Small-Molecule Inhibitors of the Wnt Pathway Potently Promote Cardiomyocytes From Human Embryonic Stem Cell–Derived Mesoderm , 2011, Circulation research.

[7]  D. Zink,et al.  Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications. , 2017, Biotechnology advances.

[8]  Sean P. Palecek,et al.  Chemically defined, albumin-free human cardiomyocyte generation , 2015, Nature Methods.

[9]  Irena Melnikova,et al.  Rare diseases and orphan drugs , 2012, Nature Reviews Drug Discovery.

[10]  K. Sasaki,et al.  Reprogramming of retinoblastoma cancer cells into cancer stem cells. , 2017, Biochemical and biophysical research communications.

[11]  A. Bradley,et al.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells , 2011, Nature.

[12]  Ronald A. Li,et al.  Calcium signalling of human pluripotent stem cell‐derived cardiomyocytes , 2013, The Journal of physiology.

[13]  Michael Schumacher,et al.  Modeling human development and disease in pluripotent stem cell-derived gastric organoids , 2014, Nature.

[14]  Wei-Zhong Zhu,et al.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. , 2013, Stem cells and development.

[15]  R. Drapkin,et al.  Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms , 2013, Front. Oncol..

[16]  H. Snoeck,et al.  Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. , 2012, Cell stem cell.

[17]  A. Hyman,et al.  CPAP promotes timely cilium disassembly to maintain neural progenitor pool , 2016, The EMBO journal.

[18]  Laura M. Palermo,et al.  A three-dimensional model of human lung development and disease from pluripotent stem cells , 2017, Nature Cell Biology.

[19]  Elizabeth E. Hoskins,et al.  Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro , 2010, Nature.

[20]  H. Sugiyama,et al.  Identification of a small molecule that turns ON the pluripotency gene circuitry in human fibroblasts. , 2014, ACS chemical biology.

[21]  Beatrice A. Howard,et al.  Prenatal Morphogenesis of Mammary Glands in Mouse and Rabbit , 2013, Journal of Mammary Gland Biology and Neoplasia.

[22]  Jonathan M. Brunger,et al.  Genome Engineering for Personalized Arthritis Therapeutics. , 2017, Trends in molecular medicine.

[23]  H. Ruohola-Baker,et al.  Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. , 2014, Journal of molecular and cellular cardiology.

[24]  N. Zavazava,et al.  Strategies to generate induced pluripotent stem cells. , 2013, Methods in molecular biology.

[25]  S. Lienkamp,et al.  Engineering kidney cells: reprogramming and directed differentiation to renal tissues , 2017, Cell and Tissue Research.

[26]  T. Shiina,et al.  Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates , 2016, Stem cell reports.

[27]  Arnold R. Kriegstein,et al.  The use of brain organoids to investigate neural development and disease , 2017, Nature Reviews Neuroscience.

[28]  Zongyou Guo,et al.  Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa , 2016, Proceedings of the National Academy of Sciences.

[29]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[30]  A. Christiano,et al.  Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells , 2011, Proceedings of the National Academy of Sciences.

[31]  G. Göhring,et al.  Generation of non-transgenic iPS cells from human cord blood CD34+ cells under animal component-free conditions. , 2017, Stem cell research.

[32]  Teruo Fujii,et al.  Organ/body-on-a-chip based on microfluidic technology for drug discovery. , 2017, Drug metabolism and pharmacokinetics.

[33]  A. Robin,et al.  Duplication of TBK1 Stimulates Autophagy in iPSC-derived Retinal Cells from a Patient with Normal Tension Glaucoma , 2014, Journal of stem cell research & therapy.

[34]  Nazish Sayed,et al.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. , 2016, Journal of the American College of Cardiology.

[35]  U. Martin.  Therapeutic Application of Pluripotent Stem Cells: Challenges and Risks , 2017, Front. Med..

[36]  Laura E Niklason,et al.  Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor. , 2014, Biomaterials.

[37]  M. Gerstein,et al.  FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders , 2015, Cell.

[38]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[39]  M. Mikkola,et al.  Genetic basis of skin appendage development. , 2007, Seminars in cell & developmental biology.

[40]  Euan A Ashley,et al.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.

[41]  E. Wolvetang,et al.  Primitive cardiac cells from human embryonic stem cells. , 2012, Stem cells and development.

[42]  E. Stanley,et al.  Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney , 2013, Nature Cell Biology.

[43]  R. Kurman.  Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  Nobutaka Hattori,et al.  Cerebral organoids model human brain development and microcephaly , 2014, Movement disorders : official journal of the Movement Disorder Society.

[45]  Carolyn M. Scott,et al.  Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium , 2016, Stem cells translational medicine.

[46]  Teruo Fujii,et al.  Generation of a Motor Nerve Organoid with Human Stem Cell-Derived Neurons , 2017, Stem cell reports.

[47]  Angela M. Christiano,et al.  Generation of 3D Skin Equivalents Fully Reconstituted from Human Induced Pluripotent Stem Cells (iPSCs) , 2013, PloS one.

[48]  G. Vunjak‐Novakovic,et al.  Highly efficient generation of airway and lung epithelial cells from human pluripotent stem cells , 2013, Nature Biotechnology.

[49]  J. D. Macklis,et al.  Modeling ALS with motor neurons derived from human induced pluripotent stem cells , 2016, Nature Neuroscience.

[50]  Tara Srinivasan,et al.  Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing , 2017, Nature Medicine.

[51]  D. Krainc,et al.  Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.

[52]  J. Gern,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients With Wiskott-Aldrich Syndrome , 2014, Pediatrics.

[53]  Jing Zhou,et al.  Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids , 2015, Nature Communications.

[54]  David W. Nauen,et al.  Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure , 2016, Cell.

[55]  Benjamin S. Freedman,et al.  Nephron organoids derived from human pluripotent stem cells model kidney development and injury , 2015, Nature Biotechnology.

[56]  M. Tomizawa,et al.  Transcription Factors and Medium Suitable for Initiating the Differentiation of Human‐Induced Pluripotent Stem Cells to the Hepatocyte Lineage , 2016, Journal of cellular biochemistry.

[57]  Da-Woon Jung,et al.  Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming. , 2014, ACS chemical biology.

[58]  S. Quaggin,et al.  Signaling during Kidney Development , 2015, Cells.

[59]  Hans Clevers,et al.  Organoid culture systems for prostate epithelial tissue and prostate cancer tissue , 2016, Nature Protocols.

[60]  Laura E Niklason,et al.  Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. , 2013, Journal of Clinical Investigation.

[61]  H. Kiyono,et al.  A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids , 2017, Stem cell reports.

[62]  Shinya Yamanaka,et al.  Induced pluripotent stem cell technology: a decade of progress , 2016, Nature Reviews Drug Discovery.

[63]  F. Cugola,et al.  Induced pluripotent stem cells for modeling neurological disorders. , 2015, World journal of transplantation.

[64]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[65]  F. Gage,et al.  Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells , 2014, Proceedings of the National Academy of Sciences.

[66]  M. Noseda,et al.  Cardiopoietic factors: extracellular signals for cardiac lineage commitment. , 2011, Circulation research.

[67]  Mathias J Friedrich,et al.  CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice , 2015, Proceedings of the National Academy of Sciences.

[68]  P. Garcez,et al.  Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.

[69]  Joseph C. Wu,et al.  Patient-specific stem cells and cardiovascular drug discovery. , 2013, JAMA.

[70]  S. Erceg,et al.  Generation of a human iPSC line by mRNA reprogramming. , 2018, Stem cell research.

[71]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[72]  Julia Gorelik,et al.  Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy? , 2011, Journal of molecular and cellular cardiology.

[73]  Ali Khademhosseini,et al.  Biomimetic tissues on a chip for drug discovery. , 2012, Drug discovery today.

[74]  L. Leinwand,et al.  The cell biology of disease Cellular mechanisms of cardiomyopathy , 2022 .

[75]  Deok‐Ho Kim,et al.  Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening. , 2017, Biotechnology advances.

[76]  T. Evans,et al.  Modeling Cystic Fibrosis Using Pluripotent Stem Cell‐Derived Human Pancreatic Ductal Epithelial Cells , 2016, Stem cells translational medicine.

[77]  Sukhdeep Singh,et al.  The future of the patient-specific Body-on-a-chip. , 2013, Lab on a chip.

[78]  S. Lopes,et al.  Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis , 2015, Nature.

[79]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[80]  F. Choy,et al.  A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells , 2017, Diseases.

[81]  Praveen Shukla,et al.  Chemically defined generation of human cardiomyocytes , 2014, Nature Methods.

[82]  Gordon Keller,et al.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. , 2012, Cell stem cell.

[83]  A. Giuliano,et al.  Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids , 2017, Stem cell reports.

[84]  C. Svendsen,et al.  Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord , 2014, The Journal of comparative neurology.

[85]  Alex P. Reiner,et al.  Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease , 2014 .

[86]  E. White,et al.  Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids , 2015, Biology Open.

[87]  Hans Clevers,et al.  Organoid Cultures Derived from Patients with Advanced Prostate Cancer , 2014, Cell.

[88]  H. Okano,et al.  Generation of human melanocytes from induced pluripotent stem cells. , 2013, Methods in molecular biology.

[89]  Alyssa J. Miller,et al.  A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids , 2016, eLife.

[90]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[91]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.

[92]  D. Geschwind,et al.  Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture , 2015, Nature Methods.

[93]  Azra Fatima,et al.  In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells , 2011, Cellular Physiology and Biochemistry.

[94]  D. Papatsenko,et al.  Modeling Familial Cancer with Induced Pluripotent Stem Cells , 2015, Cell.

[95]  Xi Ren,et al.  Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix. , 2014, The Annals of thoracic surgery.

[96]  Gordon Keller,et al.  Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. , 2011, Cell stem cell.

[97]  L. D. Del Priore,et al.  
Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases
 , 2017, The Yale journal of biology and medicine.

[98]  M. Eiraku,et al.  Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell–derived neocortex , 2013, Proceedings of the National Academy of Sciences.

[99]  M. Mahfouz,et al.  Genome editing: the road of CRISPR/Cas9 from bench to clinic , 2016, Experimental & Molecular Medicine.

[100]  A. Zorn,et al.  Differentiation of Human Pluripotent Stem Cells into Colonic Organoids via Transient Activation of BMP Signaling. , 2019, Cell stem cell.

[101]  K. Jimbow,et al.  Approach for the Derivation of Melanocytes from Induced Pluripotent Stem Cells. , 2018, The Journal of investigative dermatology.

[102]  Richard L. Frock,et al.  Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases , 2014, Nature Biotechnology.

[103]  C. Robson,et al.  Using induced pluripotent stem cells as a tool for modelling carcinogenesis. , 2015, World journal of stem cells.

[104]  Lil Pabon,et al.  Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes , 2014, Circulation research.

[105]  David V. Schaffer,et al.  Engineering adeno-associated viruses for clinical gene therapy , 2014, Nature Reviews Genetics.

[106]  G. Church,et al.  Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies , 2016, Nature Protocols.

[107]  K. Chien,et al.  How to make a cardiomyocyte , 2014, Development.

[108]  Jing Zhang,et al.  Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals , 2011, Cell Research.

[109]  L. Ellerby,et al.  iPSC-based drug screening for Huntington׳s disease , 2016, Brain Research.

[110]  N. Katsanis,et al.  Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood , 2015, Stem Cell Reviews and Reports.

[111]  Paul W. Burridge,et al.  Human Stem Cells for Modeling Heart Disease and for Drug Discovery , 2014, Science Translational Medicine.

[112]  B. Karlan,et al.  Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium , 2017, Scientific Reports.

[113]  Donald M Bers,et al.  Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays , 2013, Circulation.

[114]  W. Suh.  A new era of disease modeling and drug discovery using induced pluripotent stem cells , 2016, Archives of Pharmacal Research.

[115]  Adrian Ranga,et al.  Neural tube morphogenesis in synthetic 3D microenvironments , 2016, Proceedings of the National Academy of Sciences.

[116]  魚崎 英毅,et al.  Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression , 2011 .

[117]  R. Passier,et al.  NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes , 2011, Nature Methods.

[118]  E. Morrisey,et al.  Directing lung endoderm differentiation in pluripotent stem cells. , 2012, Cell stem cell.

[119]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[120]  J. Mayerle,et al.  Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling , 2016, Gut.